Irritable Bowel Syndrome Market: Comprehensive Analysis of Evolving Trends and Anticipated Growth Trajectory Across APAC Region | GlaxoSmithKline, TRYP Therapeutics, Urovant Sciences GmbH, Geophyt S.r.l.s., Abbvie, SOFAR S.p.A., Menarini Group, 4D pharma

DelveInsight's "Irritable Bowel Syndrome Patient Pool Analysis, Market Size and Market Forecast APAC - 2034″ report offers an in-depth understanding of the Irritable Bowel Syndrome, historical and forecasted epidemiology as well as the Irritable Bowel Syndrome market trends in the APAC region (India, China, South Korea, Taiwan, and Australia).

To Know in detail about the Irritable Bowel Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Irritable Bowel Syndrome Market Forecast
https://www.delveinsight.com/sample-request/irritable-bowel-syndrome-ibs-market-size-and-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Irritable Bowel Syndrome Market Report:
• The APAC Irritable Bowel Syndrome market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• Key Irritable Bowel Syndrome Companies: GlaxoSmithKline, TRYP Therapeutics, Urovant Sciences GmbH, Geophyt S.r.l.s., Abbvie, SOFAR S.p.A., Menarini Group, 4D pharma plc, Tioga Pharmaceuticals, Mclean Hospital, Bristol-Myers Squibb, Pharmos, Ocera Therapeutics, Furiex Pharmaceuticals, Inc, Alizyme, Mayo Clinic, Bayer, Astellas Pharma Inc, and others
• Key Irritable Bowel Syndrome Therapies: talnetant, TRYP-0082, Vibegron, Proklama, Eluxadoline, Mesalazine, Ibodutant, Blautix, Asimadoline, duloxetine, BMS-562086, Dextofisopam, Celphere® CP-305, Eluxadoline, Renzapride, Pregabalin, STW5 (Iberogast, BAY98-7411), YM060, and others
• The Irritable Bowel Syndrome market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Irritable Bowel Syndrome pipeline products will significantly revolutionize the Irritable Bowel Syndrome market dynamics.

Irritable Bowel Syndrome Overview
Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder that affects the large intestine (colon). It is characterized by symptoms such as abdominal pain, bloating, gas, and changes in bowel habits, including diarrhea, constipation, or a combination of both. The exact cause of IBS is not well understood, and it is considered a functional disorder, meaning there is no structural abnormality. Triggers for IBS symptoms can include certain foods, stress, hormonal changes, and other factors.

Get a Free sample for the Irritable Bowel Syndrome Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/irritable-bowel-syndrome-ibs-market-size-and-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Irritable Bowel Syndrome Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the APAC countries from 2020-2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Irritable Bowel Syndrome Epidemiology Segmentation:
The Irritable Bowel Syndrome market report proffers epidemiological analysis for the study period 2020-2034 in the APAC region is segmented into:
• Total Prevalence of Irritable Bowel Syndrome
• Prevalent Cases of Irritable Bowel Syndrome by severity
• Gender-specific Prevalence of Irritable Bowel Syndrome
• Diagnosed Cases of Episodic and Chronic Irritable Bowel Syndrome
Download the report to understand which factors are driving Irritable Bowel Syndrome epidemiology trends @ Irritable Bowel Syndrome Epidemiology Forecast
https://www.delveinsight.com/sample-request/irritable-bowel-syndrome-ibs-market-size-and-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Irritable Bowel Syndrome Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Irritable Bowel Syndrome market or expected to get launched during the study period. The analysis covers Irritable Bowel Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Irritable Bowel Syndrome Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Irritable Bowel Syndrome Therapies and Key Companies
• talnetant: GlaxoSmithKline
• TRYP-0082: TRYP Therapeutics
• Vibegron: Urovant Sciences GmbH
• Proklama: Geophyt S.r.l.s.
• Eluxadoline: Abbvie
• Mesalazine: SOFAR S.p.A.
• Ibodutant: Menarini Group
• Blautix: 4D pharma plc
• Asimadoline: Tioga Pharmaceuticals
• duloxetine: Mclean Hospital
• BMS-562086: Bristol-Myers Squibb
• Dextofisopam: Pharmos
• Celphere® CP-305: Ocera Therapeutics
• Eluxadoline: Furiex Pharmaceuticals, Inc
• Renzapride: Alizyme
• Pregabalin: Mayo Clinic
• STW5 (Iberogast, BAY98-7411): Bayer
• YM060: Astellas Pharma Inc
Discover more about therapies set to grab major Irritable Bowel Syndrome market share @ Irritable Bowel Syndrome Treatment Landscape
https://www.delveinsight.com/sample-request/irritable-bowel-syndrome-ibs-market-size-and-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Scope of the Irritable Bowel Syndrome Market Report
• Study Period: 2020-2034
• Coverage: APAC (India, China, South Korea, Taiwan, and Australia)
• Key Irritable Bowel Syndrome Companies: GlaxoSmithKline, TRYP Therapeutics, Urovant Sciences GmbH, Geophyt S.r.l.s., Abbvie, SOFAR S.p.A., Menarini Group, 4D pharma plc, Tioga Pharmaceuticals, Mclean Hospital, Bristol-Myers Squibb, Pharmos, Ocera Therapeutics, Furiex Pharmaceuticals, Inc, Alizyme, Mayo Clinic, Bayer, Astellas Pharma Inc, and others
• Key Irritable Bowel Syndrome Therapies: talnetant, TRYP-0082, Vibegron, Proklama, Eluxadoline, Mesalazine, Ibodutant, Blautix, Asimadoline, duloxetine, BMS-562086, Dextofisopam, Celphere® CP-305, Eluxadoline, Renzapride, Pregabalin, STW5 (Iberogast, BAY98-7411), YM060, and others
• Irritable Bowel Syndrome Therapeutic Assessment: Irritable Bowel Syndrome current marketed and Irritable Bowel Syndrome emerging therapies
• Irritable Bowel Syndrome Market Dynamics: Irritable Bowel Syndrome market drivers and Irritable Bowel Syndrome market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Irritable Bowel Syndrome Unmet Needs, KOL's views, Analyst's views, Irritable Bowel Syndrome Market Access and Reimbursement

To know more about Irritable Bowel Syndrome companies working in the treatment market, visit @ Irritable Bowel Syndrome Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/irritable-bowel-syndrome-ibs-market-size-and-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Irritable Bowel Syndrome Market Report Introduction
2. Executive Summary for Irritable Bowel Syndrome
3. SWOT analysis of Irritable Bowel Syndrome
4. Irritable Bowel Syndrome Patient Share (%) Overview at a Glance
5. Irritable Bowel Syndrome Market Overview at a Glance
6. Irritable Bowel Syndrome Disease Background and Overview
7. Irritable Bowel Syndrome Epidemiology and Patient Population
8. Country-Specific Patient Population of Irritable Bowel Syndrome
9. Irritable Bowel Syndrome Current Treatment and Medical Practices
10. Irritable Bowel Syndrome Unmet Needs
11. Irritable Bowel Syndrome Emerging Therapies
12. Irritable Bowel Syndrome Market Outlook
13. Country-Wise Irritable Bowel Syndrome Market Analysis (2020-2034)
14. Irritable Bowel Syndrome Market Access and Reimbursement of Therapies
15. Irritable Bowel Syndrome Market Drivers
16. Irritable Bowel Syndrome Market Barriers
17. Irritable Bowel Syndrome Appendix
18. Irritable Bowel Syndrome Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Latest Reports by DelveInsight
Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market
"DelveInsight's 'Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +14699457679
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.